Background Radial artery occlusion (RAO) occurs in 1% to 10% of cases following transradial arterial access (TRA) for neuroendovascular procedures. When repeat access is required in patients discovered to have RAO, a transfemoral approach is often used. This study reports experience with repeat TRA procedures at a single center and techniques for reaccessing an occluded radial artery in select patients.
Methods The electronic records of all patients who underwent multiple neuroendovascular procedures with an attempted TRA as the index procedure at a single center from July 2019 through February 2020 were reviewed.
Results There were 656 TRA attempts for diagnostic angiography or intervention from July 2019 through February 2020. A total of 106 patients underwent a repeated attempt at TRA. Techniques for reaccessing an occluded radial artery were implemented halfway through the study period. One hundred patients (94.3%) had a successful second radial catheterization. Six patients required conversion to a transfemoral approach: five for RAO and one for radial branch perforation during the index procedure. After we implemented our techniques for reaccess, four additional patients with RAO successfully underwent TRA. There were no short-term complications, including pain, vessel perforation, forearm hematoma, or hand ischemia, following successful repeat catheterization of a previously occluded radial artery.
Conclusion RAO is not an absolute limitation for attempting TRA in patients undergoing repeat catheterization. Reaccessing the radial artery after occlusion is feasible for repeat neuroendovascular procedures.
Statistics from Altmetric.com
Contributors Primary writing of the text, manuscript preparation, data collection, and interpretation and approval of the text: NM, DAW, AFD, and FCA. Assistance with manuscript preparation and critical revision, data collection and interpretation, and approval of the text: JSC, TSC, and JFB. Project design: NM, AFD, and FCA. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: NM, DAW, JSC, TSC, JFB, AFD, and FCA.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.
Competing interests AFD is a consultant for Medtronic (Dublin, Ireland); Cerenovus (Johnson & Johnson, New Brunswick, NJ); Stryker (Kalamazoo, MI); Penumbra (Alameda, CA); and Koswire, Inc (Flowery Branch, GA).
Patient consent for publication Not required.
Ethics approval This study was approved under IRB PHX-18-500-415-73-12.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement No data are available. There are no additional data to share.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.